The bone cement market is projected to grow at a CAGR of 6.63% to reach a market size of US$704.854 million in 2024 from US$479.538 million in 2018. Bone cement is commonly known as polymethylmethacrylate and is widely used for implant fixation in various orthopedic, dental, and trauma surgeries.

Bone cement has no intrinsic adhesive properties; however, it relies on close mechanical interlock between the irregular bone surface and the prosthesis. Commercially, bone cement is available as calcium phosphate cement and glass polyalkenoate cement. CPC is bioabsorbable and biocompatible, used primarily in cranial and maxillofacial surgeries due to its low mechanical strength.

The bone cement market has been segmented based on By type, By application, By antibiotic type, 
By viscosity, By end-user, and By geography.